CRNX
Crinetics Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$84.95
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 76.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.56x
- Price / sales
- 213.80x
- Price / cash flow
- -21.33x
Enterprise value
- Enterprise value
- $7.9B
- EV / sales
- 186.31x
- EV / EBITDA
- -15.44x
- EV / EBIT
- -14.30x
- Market cap
- $9.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026